Stay updated on Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Sign up to get notified when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.

Latest updates to the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.7%
- Check11 days agoChange DetectedThe page has removed two significant studies related to obesity treatment and metabolic syndrome, while adding the same studies without their erratum details.SummaryDifference0.3%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page has removed several important references related to weight loss studies involving liraglutide, which may affect the credibility and comprehensiveness of the content on weight management.SummaryDifference0.7%
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check47 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a clinical study on liraglutide and its implications for obesity and cardiovascular disease, while retaining the study's collaborators and revision information.SummaryDifference14%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.